CoChat
Sign Up
Cited by 82

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway

Contreras-Paredes, Adriana, De la Cruz-Hernández, Erick, Martínez-Ramírez, Imelda, Dueñas-González, Alfonso, Lizano, Marcela·2009·Virology
DOI 10.1016/j.virol.2008.09.040
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.virol.2008.09.040

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 58

  1. Adey, 2000, Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding, Cancer Res., 60, 35
  2. Bertelsen, 2006, Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation, Int. J. Cancer, 118, 1877, 10.1002/ijc.21461 · DOI
  3. Bosch, 2002, The causal relation between human papillomavirus and cervical cancer, J. Clin. Pathol., 55, 244, 10.1136/jcp.55.4.244 · DOI
  4. Chai, 2007, Melanocortin-3 receptor activates MAP kinase via PI3 kinase, Regul. Pept., 139, 115, 10.1016/j.regpep.2006.11.003 · DOI
  5. Chakrabarti, 2004, Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Res, J. Virol., 78, 5934, 10.1128/JVI.78.11.5934-5945.2004 · DOI
  6. Cheung, 2004, Epigenetic and genetic alternation of PTEN in cervical neoplasm, Gynecol. Oncol., 93, 621, 10.1016/j.ygyno.2004.03.013 · DOI
  7. Dalstein, 2003, Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study, Int. J. Cancer, 106, 396, 10.1002/ijc.11222 · DOI · Paper page
  8. De la Cruz, 2005, Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences, J. Gen.Virol., 86, 2459, 10.1099/vir.0.80945-0 · DOI
  9. Donzé, O., Picard, D., 2002. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucl. Ac. Res. 15, 30, e46. · DOI
  10. Downward, 2004, PI 3-kinase, Akt and cell survival, Semin. Cell Dev. Biol., 15, 177, 10.1016/j.semcdb.2004.01.002 · DOI
  11. Graness, 1998, Novel mitogenic signaling pathway of bradykinin in the human colon carcinoma cell line SW-480 involves sequential activation of a Gq/11 protein, phosphatidylinositol 3-kinase beta, and protein kinase Cepsilon, J. Biol. Chem., 273, 32016, 10.1074/jbc.273.48.32016 · DOI
  12. Grm, 2004, Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent, J. Gen. Virol., 85, 2815, 10.1099/vir.0.80035-0 · DOI
  13. Haluska, 2006, Genetic alterations in signaling pathways in melanoma, Clin. Cancer Res., 12, 2301s, 10.1158/1078-0432.CCR-05-2518 · DOI
  14. Harima, 2001, Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy, Int. J. Oncol., 18, 493
  15. Herman, 1996, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands, Proc. Natl. Acad. Sci. U. S. A., 93, 9821, 10.1073/pnas.93.18.9821 · DOI
  16. Hildesheim, 2001, Human papillomavirus type 16 variants and risk of cervical cancer, J. Natl. Cancer Inst., 93, 315, 10.1093/jnci/93.4.315 · DOI
  17. Ishidate, 2000, The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase, Oncogene, 19, 365, 10.1038/sj.onc.1203309 · DOI
  18. Jeong, 2007, Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation, Oncogene, 26, 487, 10.1038/sj.onc.1209837 · DOI
  19. Jorda, 2007, Id-1 is induced in MDCK epithelial cells by activated Erk/MAPK pathway in response to expression of the Snail and E47 transcription factors, Exp. Cell. Res., 3, 2389, 10.1016/j.yexcr.2007.04.001 · DOI
  20. Kammer, 2002, Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease, Br. J. Cancer, 86, 269, 10.1038/sj.bjc.6600024 · DOI
  21. Knobbe, 2003, Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas, Brain Pathol., 13, 507, 10.1111/j.1750-3639.2003.tb00481.x · DOI
  22. Kranenburg, 1997, Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc, EMBO J., 16, 3097, 10.1093/emboj/16.11.3097 · DOI
  23. Kurose, 2000, Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas, Genes Chromosomes Cancer, 29, 166, 10.1002/1098-2264(2000)9999:9999<::AID-GCC1025>3.0.CO;2-M · DOI
  24. Laprise, 2004, Human Homolog of Disc-large is required for Adherens junction assembly and differentiation of human intestinal Epithelial cells⁎, J. Biol. Chem., 279, 10166, 10.1074/jbc.M309843200 · DOI
  25. Lawlor, 2001, PKB/Akt: a key mediator of cell proliferation, survival and insulin responses, J. Cell Sci., 114, 2903, 10.1242/jcs.114.16.2903 · DOI
  26. Lee, 1997, Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein, Proc. Natl. Acad. Sci. U. S. A., 94, 6670, 10.1073/pnas.94.13.6670 · DOI · Paper page
  27. Lee, 2006, Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma, J. Surg. Oncol., 93, 233, 10.1002/jso.20493 · DOI
  28. Li, 1997, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science, 275, 1943, 10.1126/science.275.5308.1943 · DOI · Paper page
  29. Lin, 2004, Differential expression of human Dlg in cervical intraepithelial neoplasias, Gynecol. Oncol., 93, 422, 10.1016/j.ygyno.2004.01.025 · DOI
  30. Lizano, 1997, Association between human papillomavirus type 18 variants and histopathology of cervical cancer, J. Natl. Cancer Inst., 89, 1227, 10.1093/jnci/89.16.1227 · DOI
  31. Ma, 2000, PIK3CA as an oncogene in cervical cancer, Oncogene, 19, 2739, 10.1038/sj.onc.1203597 · DOI
  32. Malanchi, 2004, Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression, J. Virol., 78, 13769, 10.1128/JVI.78.24.13769-13778.2004 · DOI
  33. Mantovani, 2001, The human papillomavirus E6 protein and its contribution to malignant progression, Oncogene, 20, 7874, 10.1038/sj.onc.1204869 · DOI
  34. Mantovani, 2001, Proteasome-mediated regulation of the hDlg tumour suppressor protein, J. Cell. Sci., 114, 4285, 10.1242/jcs.114.23.4285 · DOI
  35. Massimi, 2004, HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation, Oncogene, 23, 8033, 10.1038/sj.onc.1207977 · DOI
  36. Mei, 2005, Indole-3-carbinol prevents PTEN loss in cervical cancer in vivo, Mol Med., 11, 59, 10.2119/2006-00007.Auborn · DOI
  37. Motoyama, 2004, The role of human papilloma virus in the molecular biology of cervical carcinogenesis, Kobe J. Med. Sci., 50, 9
  38. Nair, 2003, Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway, J. Virol., 77, 7106, 10.1128/JVI.77.12.7106-7112.2003 · DOI
  39. Pedrero, 2005, Frequent genetic and biochemical alterations of the PI 3-K/AKT/PKB/PTEN pathway in head and neck squamous cell carcinoma, Int. J. Cancer, 114, 242, 10.1002/ijc.20711 · DOI
  40. Pim, 2005, Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A, Oncogene, 24, 7830, 10.1038/sj.onc.1208935 · DOI · Paper page
  41. Roymans, 2001, Phosphatidylinositol 3-kinases in tumor progression, Eur. J. Biochem., 268, 487, 10.1046/j.1432-1327.2001.01936.x · DOI
  42. Sansal, 2004, The biology and clinical relevance of the PTEN Tumor suppressor Pathway, J. Clinical Oncol., 14, 2963
  43. Stoppler, 1996, Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation, J. Virol., 70, 6987, 10.1128/jvi.70.10.6987-6993.1996 · DOI
  44. Su, 2000, Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer, Gynecol. Oncol., 76, 193, 10.1006/gyno.1999.5659 · DOI
  45. Tak-Hong, 2004, Epigenetic and genetic alternation of PTEN in cervical neoplasm, Gynecol. Oncol., 93, 621, 10.1016/j.ygyno.2004.03.013 · DOI
  46. Tashiro, 1997, Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies, Cancer Res., 57, 1940
  47. Thomas, 2001, HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation, Oncogene, 20, 5431, 10.1038/sj.onc.1204719 · DOI
  48. Tsugawa, 2002, Biological role of phosphatase PTEN in cancer and tissue injury healing, Front. Biosci., 7e, 245, 10.2741/tsugawa · DOI
  49. Valiente, 2005, Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases, J. Biol. Chem., 280, 28936, 10.1074/jbc.M504761200 · DOI
  50. Watson, 2002, Changes in expression of the human homologue of the Drosophila discs large tumour suppressor protein in high-grade premalignant cervical neoplasias, Carcinogenesis, 23, 1791, 10.1093/carcin/23.11.1791 · DOI
  51. Wells, 2007, Functional inhibition of PI3K by the bGBP molecule suppresses Ras-MAPK signaling to block cell proliferation, Oncogene, 26, 7709, 10.1038/sj.onc.1210580 · DOI
  52. Wennstrom, 1999, Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor, Mol. Cell. Biol., 19, 4279, 10.1128/MCB.19.6.4279 · DOI
  53. Yaginuma, 2000, Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers, Mol. Carcinog., 27, 110, 10.1002/(SICI)1098-2744(200002)27:2<110::AID-MC6>3.0.CO;2-E · DOI
  54. Yamato, 2006, Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA, Cancer Gene Ther., 13, 234, 10.1038/sj.cgt.7700891 · DOI
  55. Yang, 2006, Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data, BMC Cancer, 6, 212, 10.1186/1471-2407-6-212 · DOI
  56. Zhang, 2007, Structures of a human Papillomavirus (HPV) E6 polypeptide bound MAGUK Proteins: mechanisms of targeting tumor suppressors by a high risk HPV oncoprotein, J. Virol., 81, 3618, 10.1128/JVI.02044-06 · DOI
  57. zur Hausen, 2002, Papillomaviruses and cancer: from basic studies to clinical application, Nat. Rev., Cancer, 2, 342, 10.1038/nrc798 · DOI
  58. Zysman, 2002, Considerations when analyzing the methylation status of PTEN tumor suppressor gene, Am. J. Pathol., 160, 795, 10.1016/S0002-9440(10)64902-4 · DOI

Cited by

See all 82

Metadata

Authors
Contreras-Paredes, A., De la Cruz-Hernández, E., Martínez-Ramírez, I., Dueñas-González, A., & Lizano, M.
Venue
Virology
Publisher
Elsevier BV
Published
2009-01
Volume
383
Issue
1
Pages
78-85
ISSN
0042-6822
DOI
10.1016/j.virol.2008.09.040
Cited by
82
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review